COVID-19

Pfizer: Vaccine trial has 'robust immune response'

The Trump administration will pay Pfizer nearly $2 billion for a December delivery of 100 million doses of a COVID-19 vaccine the pharmaceutical company is developing. (July 22)

Subscribe for more Breaking News:
Website:
Twitter:
Facebook:
Google+:
Instagram:

You can license this story through AP Archive: